Md. Code, Insurance § 15-1635
This is the official text of Md. Code, Insurance § 15-1635, part of Maryland’s Code, Insurance — regulates insurance companies and the policies they sell.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
§15–1635.
Official statutory text
If a therapeutic interchange occurs, the pharmacy benefits manager or its agent shall:
(1) disclose to the beneficiary, orally or in writing:
(i) that the pharmacy benefits manager or its agent requested a therapeutic interchange by contacting the beneficiary’s prescriber;
(ii) the prescriber approved the therapeutic interchange;
(iii) the names of the originally prescribed drug and the drug dispensed pursuant to the therapeutic interchange;
(iv) the difference in copayments or coinsurance to be paid by the beneficiary to obtain the drug dispensed pursuant to the therapeutic interchange;
(v) the circumstances under which the originally prescribed drug will be covered;
(vi) the circumstances under and the extent to which health care costs related to the therapeutic interchange will be compensated; and
(vii) that the beneficiary may decline the therapeutic interchange if the originally prescribed drug remains on the beneficiary’s formulary, and the beneficiary is willing to pay any difference in the copayment or coinsurance; and
(2) include with the prescription drug dispensed:
(i) a patient package insert about potential side effects; and
(ii) a toll–free telephone number to communicate with the pharmacy benefits manager.
(1) disclose to the beneficiary, orally or in writing:
(i) that the pharmacy benefits manager or its agent requested a therapeutic interchange by contacting the beneficiary’s prescriber;
(ii) the prescriber approved the therapeutic interchange;
(iii) the names of the originally prescribed drug and the drug dispensed pursuant to the therapeutic interchange;
(iv) the difference in copayments or coinsurance to be paid by the beneficiary to obtain the drug dispensed pursuant to the therapeutic interchange;
(v) the circumstances under which the originally prescribed drug will be covered;
(vi) the circumstances under and the extent to which health care costs related to the therapeutic interchange will be compensated; and
(vii) that the beneficiary may decline the therapeutic interchange if the originally prescribed drug remains on the beneficiary’s formulary, and the beneficiary is willing to pay any difference in the copayment or coinsurance; and
(2) include with the prescription drug dispensed:
(i) a patient package insert about potential side effects; and
(ii) a toll–free telephone number to communicate with the pharmacy benefits manager.
Status: in_force · Read it on the official government site
Need a lawyer in Maryland?
Find a Maryland lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.